Title : Evaluating the cognitive effects of donepezil 23 mg\/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response - Sabbagh_2013_BMC.Geriatr_13_56 |
Author(s) : Sabbagh M , Cummings J , Christensen D , Doody R , Farlow M , Liu L , Mackell J , Fain R |
Ref : BMC Geriatr , 13 :56 , 2013 |
Abstract :
BACKGROUND: Treatment of Alzheimer's disease with acetylcholinesterase inhibitors can result in symptomatic benefits, but patients often show variable responses. The objective of this post hoc analysis was to investigate relationships between easily identifiable baseline characteristics/demographics and cognitive response in patients treated with either donepezil 23 mg/d or 10 mg/d and to identify factors potentially influencing response. |
PubMedSearch : Sabbagh_2013_BMC.Geriatr_13_56 |
PubMedID: 23742728 |
Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R (2013)
Evaluating the cognitive effects of donepezil 23 mg\/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response
BMC Geriatr
13 :56
Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R (2013)
BMC Geriatr
13 :56